Valuation: Ovation Science Inc.

Market Cap 1.15M 822K 737K 682K 617K 78.26M 1.17M 8.15M 3.25M 40.95M 3.08M 3.02M 130M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 1.36M 972K 872K 806K 730K 92.56M 1.38M 9.64M 3.84M 48.43M 3.65M 3.57M 154M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.96%
Yield 2024 *
-
Yield 2025 -
1 day+50.00%
3 months+50.00%
6 months+20.00%
Current year-25.00%
Current year 0.02
Extreme 0.015
0.04
1 year 0.02
Extreme 0.015
0.05
3 years 0.01
Extreme 0.01
0.08
5 years 0.01
Extreme 0.01
0.1
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Director of Finance/CFO 63 30/10/2023
Chief Executive Officer 77 04/10/2017
Director of Finance/CFO 60 20/10/2026
Director TitleAgeSince
Director/Board Member 77 04/10/2017
Director/Board Member 63 04/10/2017
Director/Board Member 86 02/02/2018
Date Insider Type Main position Quantity % Market Cap. Importance
7/4/25 Buy

Director

100,000 0.2642%
31/1/25 Other

Director

0 0%
31/1/25 Buy

Director

100,000 0.2642%
Change 5-day change 1-year change 3-year change Capi.($)
+50.00%-.--%-33.33%+50.00% 821K
-0.61%+0.91%+4.55%+6.03% 369B
-1.50%+4.88%+12.78%+8.48% 255B
-2.05%-2.27%-8.75%+11.48% 140B
-0.52%-1.83%+18.86%+24.11% 73.48B
+0.11%+5.83%+32.57% - 52.06B
-0.12%-2.02%-27.71%-26.84% 44.97B
+0.89%+5.45%+10.68%-14.58% 39.2B
-0.51%+1.52%+33.22%+3.70% 37.32B
-0.64%+1.65%-10.16%-9.30% 36.28B
Average +4.64%+0.76%+3.27%+5.90% 104.77B
Weighted average by Cap. -0.52%+1.22%+6.53%+5.82%

Financials

2024 2025
Net sales 113K 80.66K 72.37K 66.91K 60.6K 7.68M 115K 800K 319K 4.02M 303K 296K 12.76M 67.89K 48.37K 43.4K 40.12K 36.34K 4.61M 68.71K 480K 191K 2.41M 182K 178K 7.65M
Net income -456K -325K -292K -270K -244K -30.96M -462K -3.22M -1.28M -16.2M -1.22M -1.19M -51.43M -631K -450K -404K -373K -338K -42.84M -639K -4.46M -1.78M -22.42M -1.69M -1.65M -71.16M
Net Debt 265K 189K 170K 157K 142K 17.99M 268K 1.87M 746K 9.42M 709K 694K 29.89M 211K 150K 135K 125K 113K 14.3M 213K 1.49M 593K 7.48M 564K 552K 23.76M
Projected Income Statement - Annual - Ovation Science Inc.
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
  1. Stock Market
  2. Stocks
  3. OVAT Stock